[Skip to Content]
[Skip to Content Landing]
Article
August 1968

Erythrodermic Psoriasis in Childhood: A Young Negro Child Treated With Methotrexate

Author Affiliations

Washington DC
From the Department of Pediatrics, Howard University College of Medicine, and the Pediatric Service, Freedmen's Hospital, Washington, DC.

Am J Dis Child. 1968;116(2):218-221. doi:10.1001/archpedi.1968.02100020220018
Abstract

PSORIASIS is a chronic inflammatory skin disorder of unknown etiology and and inconstant course. It is said to occur in 1% to 2% of the white population, but is rare in Negroes.1 The disease is relatively uncommon in the pediatric age range, particularly in children under 3 years of age.2 The diffuse erythrodermic form is extremely rare in young children.3,4

The purpose of this report is to present a case of erythrodermic psoriasis in a Negro child whose disease began about 18 months of life. Perlman states that psoriasis is uncommon in Negroes.2 Our case is of further interest because it illustrates problems in differential diagnosis, particularly for the pediatrician. We also wish to report our experience with the use of methotrexate as a therapeutic agent in this intractable disease.

Report of a Case  A Negro boy was admitted to Freedmen's Hospital at the age of

×